BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, May 2, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for April 6, 2023

April 6, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Food Allergy Institute.
Read More

In the clinic for April 6, 2023

April 6, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AI, Algernon, Aurinia, Avacta, Beckley Psytech, Bellus, Benevolentai, Cingulate, Deka, Endogena, Immunic, Infex, Lipella, Morphosys, Palisade, Small, Y-mabs.
Read More

In the clinic for April 5, 2023

April 5, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: C2n Diagnostics.
Read More

In the clinic for April 5, 2023

April 5, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alzamend, Alterity, Arrowhead, Axial, Bioarctic, EIP, Eisai, Innocare, Iomx, Lundbeck, Lynk, Mythic, Otsuka, Precision, Skye, Sobi, Takeda.
Read More

In the clinic for March 28-April 3, 2023

April 4, 2023
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Actinogen Medical, Bioxytran, Dxvx C., Eisai, Immutep, Invivyd, Kintor, Olix, Takeda, Vacmedix UK, Yishengbio.
Read More

In the clinic for April 4, 2023

April 4, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abcuro, Akebia, Ascendis, Alzamed, Citius, Contrafect, Corvus, Ensysce, Fibrogen, Kodiak, Lipocine, Oncosec, Oryzon, Pardes, Scioto, Travere, Vico.
Read More

In the clinic for April 3, 2023

April 3, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Juno Diagnostics.
Read More

In the clinic for April 3, 2023

April 3, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Almirall, Anavex Life Sciences, Curasen, Cytokinetics, Eisai, Eledon, Eli Lilly, Hansa, Immutep, Insmed, Invivyd.
Read More

In the clinic for March 31, 2023

March 31, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Coloplast, Creo Medical, Mainz Biomed.
Read More

In the clinic for March 31, 2023

March 31, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinogen, Aldeyra, Asklepios, Atreca, Avalyn, Avidity, BMS, Bolt, Immutep, Janssen, Medicenna, Nanoscope, Oxford Vacmedix, PDS, Renovorx, Seelos, Sustained, Takeda, Tonix, Vaxcyte, Vyne.
Read More
Previous 1 2 … 142 143 144 145 146 147 148 149 150 … 322 323 Next

Popular Stories

  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing